Syneron Medical Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Syneron Medical Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011932
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月14日
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Syneron Medical Ltd (Syneron) is an aesthetic medical device company. It designs, develops and markets aesthetic medical products. The company products target a range of non-invasive aesthetic medical procedures and address wide range of cosmetic and medical indications such as treatment of leg veins, acne treatment, wrinkle reduction, hair removal, skin rejuvenation of the skin’s appearance, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and a minimally invasive product for laser-assisted lipolysis. Syneron utilizes various technologies including its proprietary Electro-Optical Synergy (ELOS) technology to develop aesthetic medical products. It sells products through a network of distributors and subsidiaries located in the US, Canada, Israel, Spain, France, Germany, Italy, Portugal, the UK, China, Hong Kong, Japan and Australia. Syneron is headquartered in Yokneam Illit, Israel.

Syneron Medical Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Syneron Medical Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Syneron Medical Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Syneron Medical Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Syneron Medical Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Syneron Medical Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Syneron Medical Ltd, Medical Equipment, Deal Details 11
Private Equity 11
Apax Partners Acquires Syneron Medical for USD400 Million 11
Partnerships 13
Syneron Medical and Allergan Enter into Agreement 13
Syneron Medical Forms Joint Venture With Unilever Ventures 14
Palomar Medical Enters Into Licensing Agreement With Candela And Syneron 15
Palomar Medical Enters Into Licensing Agreement With Syneron Medical 16
Acquisition 17
Sino-Lite to Acquire Light Instruments from Syneron Medical 17
Syneron Medical Acquires New Star Lasers For US$15 Million 18
Syneron Medical Acquires Minority Stake In Juvenis For Up To US$4 Million 19
Syneron Medical To Acquire TransPharma Medical For US$3.6 Million 20
Syneron Medical Completes Acquisition Of Ultrashape From Ultrashape Medical For US$12 Million 22
Syneron Medical Ltd – Key Competitors 24
Syneron Medical Ltd – Key Employees 25
Syneron Medical Ltd – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 27
Recent Developments 28
Financial Announcements 28
May 17, 2017: Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million 28
Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million 30
Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million 32
Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue 33
Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09 34
May 19, 2016: Syneron Medical Reports First Quarter 2016 Revenue of $68.7 Million 36
Feb 22, 2016: Syneron Medical Reports Record Fourth Quarter 2015 Revenue of $78.9 Million 37
Jan 11, 2016: Syneron Medical Provides Preliminary Fourth Quarter 2015 Revenue 39
Corporate Communications 40
Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer 40
Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 41
Product News 42
03/03/2016: Syneron Candela to Introduce SubQ Profound Applicator at the 2016 American Academy of Dermatology Annual Meeting 42
03/03/2016: Syneron Candela to Introduce Ultra-Short PicoWay Laser at the 2016 American Academy of Dermatology Annual Meeting 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Syneron Medical Ltd, Medical Equipment, Key Facts, 2016 2
Syneron Medical Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Syneron Medical Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Syneron Medical Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Syneron Medical Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Syneron Medical Ltd, Deals By Market, 2011 to YTD 2017 9
Syneron Medical Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Apax Partners Acquires Syneron Medical for USD400 Million 11
Syneron Medical and Allergan Enter into Agreement 13
Syneron Medical Forms Joint Venture With Unilever Ventures 14
Palomar Medical Enters Into Licensing Agreement With Candela And Syneron 15
Palomar Medical Enters Into Licensing Agreement With Syneron Medical 16
Sino-Lite to Acquire Light Instruments from Syneron Medical 17
Syneron Medical Acquires New Star Lasers For US$15 Million 18
Syneron Medical Acquires Minority Stake In Juvenis For Up To US$4 Million 19
Syneron Medical To Acquire TransPharma Medical For US$3.6 Million 20
Syneron Medical Completes Acquisition Of Ultrashape From Ultrashape Medical For US$12 Million 22
Syneron Medical Ltd, Key Competitors 24
Syneron Medical Ltd, Key Employees 25
Syneron Medical Ltd, Subsidiaries 26
Syneron Medical Ltd, Joint Venture 27

★海外企業調査レポート[Syneron Medical Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HighPoint Resources Corp (BBG):企業の財務・戦略的SWOT分析
    Summary HighPoint Resources Corp (HighPoint Resources) formerly Bill Barrett Corp, is an oil and gas company that explores and produces crude oil and natural gas. The company develops and operates oil and natural gas assets located in the Denver-Julesburg Basin of Colorado. Its Denver-Julesburg Basi …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Tesla, Inc (TSLA):電力:M&Aディール及び事業提携情報
    Summary Tesla, Inc. (Tesla), formerly Tesla Motors, Inc., is an automotive and vertically integrated sustainable energy company. It designs, develops, manufactures and sells electric vehicles and energy storage products. The company also installs and maintains electric vehicles and energy storage sy …
  • Energy Development Corp (EDC):電力:M&Aディール及び事業提携情報
    Summary Energy Development Corp (EDC), formerly Philippine National Oil Company, is a diversified renewable energy company. The company explores, develops, operates and utilizes geothermal energy and other indigenous renewable energy projects in the Philippines. EDC by utilizing geothermal energy an …
  • LafargeHolcim Ltd.:企業のM&A・事業提携・投資動向
    LafargeHolcim Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's LafargeHolcim Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Carnival Corporation & Plc (CCL):企業の財務・戦略的SWOT分析
    Carnival Corporation & Plc (CCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bluefish Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Bluefish Pharmaceuticals AB (Bluefish Pharmaceuticals) is a pharmaceutical company that develops, manufactures and distributes generic pharmaceuticals. The company offers products in the therapeutic areas of cardiovascular, central nervous system, gastrointestinal, diabetes, oncology, dermat …
  • Jones Soda Co.:企業の戦略・SWOT・財務情報
    Jones Soda Co. - Strategy, SWOT and Corporate Finance Report Summary Jones Soda Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • CynergisTek, Inc. (CTEK):企業の戦略的SWOT分析
    CynergisTek, Inc. (CTEK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • ImaginAb Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImaginAb Inc (ImaginAb) is an immune and oncology imaging company that develops in vivo antibody-based imaging agents. It is engaged in the discovery, development, and production of new compounds and products in human health and cosmetics, agriculture and food sectors. The company’s product …
  • Sekisui House Ltd (1928):企業の財務・戦略的SWOT分析
    Sekisui House Ltd (1928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Emerald Resources NL (EMR):石油・ガス:M&Aディール及び事業提携情報
    Summary Emerald Resources NL (Emerald) is an oil and gas company that carries out mineral exploration and development. The company carries out acquisition, exploration, development and produces oil and natural gas, and gold deposits. Its projects include Okavu Gold project, and Magoffin County proje …
  • Eastern Platinum Limited:企業の戦略・SWOT・財務情報
    Eastern Platinum Limited - Strategy, SWOT and Corporate Finance Report Summary Eastern Platinum Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kura Oncology Inc (KURA)-製薬・医療分野:企業M&A・提携分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company which discovers and develops therapeutics for the treatment of solid tumors and blood cancers. Its lead drug candidate, Tipifarnib, an inhibitor of protein farnesylation, is a small molecule that targets oncogene …
  • F-star Biotechnology Ltd-製薬・医療分野:企業M&A・提携分析
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …
  • Edgewell Personal Care LLC (EPC):企業の財務・戦略的SWOT分析
    Edgewell Personal Care LLC (EPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Liburnia Riviera Hoteli d.d.:企業の戦略・SWOT・財務情報
    Liburnia Riviera Hoteli d.d. - Strategy, SWOT and Corporate Finance Report Summary Liburnia Riviera Hoteli d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • POET Technologies Inc (PTK):電力:M&Aディール及び事業提携情報
    Summary POET Technologies Inc (POET), a subsidiary of Pinetree Capital Ltd, is a technology company that develops integrated circuit platforms. The company provides products such as narrow linewidth laser, broadband light sources, data communications products and active and passive components, among …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆